EA202000347A1 - ANTI-SARS-CoV-2 VIRAL AGENT ANTIPROVIR - Google Patents

ANTI-SARS-CoV-2 VIRAL AGENT ANTIPROVIR

Info

Publication number
EA202000347A1
EA202000347A1 EA202000347A EA202000347A EA202000347A1 EA 202000347 A1 EA202000347 A1 EA 202000347A1 EA 202000347 A EA202000347 A EA 202000347A EA 202000347 A EA202000347 A EA 202000347A EA 202000347 A1 EA202000347 A1 EA 202000347A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antiprovir
cov
sars
prevention
viral agent
Prior art date
Application number
EA202000347A
Other languages
Russian (ru)
Inventor
Андрей Александрович ИВАЩЕНКО
Александр Васильевич ИВАЩЕНКО
Николай Филиппович САВЧУК
Алёна Александровна Иващенко
Владимир Григорьевич ЛОГИНОВ
Михаил ТОПР
Original Assignee
Андрей Александрович ИВАЩЕНКО
Александр Васильевич ИВАЩЕНКО
Николай Филиппович САВЧУК
Алёна Александровна Иващенко
Владимир Григорьевич ЛОГИНОВ
Михаил ТОПР
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2020116573A external-priority patent/RU2738885C1/en
Priority claimed from RU2020123217A external-priority patent/RU2020123217A/en
Application filed by Андрей Александрович ИВАЩЕНКО, Александр Васильевич ИВАЩЕНКО, Николай Филиппович САВЧУК, Алёна Александровна Иващенко, Владимир Григорьевич ЛОГИНОВ, Михаил ТОПР filed Critical Андрей Александрович ИВАЩЕНКО
Publication of EA202000347A1 publication Critical patent/EA202000347A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к новому противо-SARS-CoV-2 вирусному средству Антипровир, предназначенному для профилактики и лечения короновирусного заболевания COVID-19. Применение фармацевтической композиции, в том числе Апротекс, Гордокс и Аэрус, включающие в качестве активного компонента апротинин и вспомогательные вещества, в качестве противо-SARS-CoV-2 вирусного лекарственного средства Антипровир для профилактики и лечения короновирусного заболевания COVID-19. Лекарственное средство Антипровир для профилактики и лечения короновирусного заболевания COVID-19, представляющее собой фармацевтическую композицию, содержащую 0,1-0,2 вес.% апротинина, необязательно 0,2-1,0 вес.% вспомогательных веществ и остальное - вода для инъекций.The invention relates to a new anti-SARS-CoV-2 viral agent Antiprovir, intended for the prevention and treatment of coronavirus disease COVID-19. The use of a pharmaceutical composition, including Aprotex, Gordox and Aerus, containing aprotinin and excipients as an active component, as an anti-SARS-CoV-2 viral drug Antiprovir for the prevention and treatment of coronavirus disease COVID-19. Antiprovir drug for the prevention and treatment of coronavirus disease COVID-19, which is a pharmaceutical composition containing 0.1-0.2 wt.% Aprotinin, optionally 0.2-1.0 wt.% Excipients and the rest is water for injection ...

EA202000347A 2020-04-30 2020-12-04 ANTI-SARS-CoV-2 VIRAL AGENT ANTIPROVIR EA202000347A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2020116573A RU2738885C1 (en) 2020-04-30 2020-04-30 Anti-sars-cov-2 viral agent antiprovir
RU2020123217A RU2020123217A (en) 2020-07-13 2020-07-13 Anti-SARS-CoV-2 virus agent Antiprovir

Publications (1)

Publication Number Publication Date
EA202000347A1 true EA202000347A1 (en) 2021-11-30

Family

ID=78373752

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202000347A EA202000347A1 (en) 2020-04-30 2020-12-04 ANTI-SARS-CoV-2 VIRAL AGENT ANTIPROVIR

Country Status (2)

Country Link
EA (1) EA202000347A1 (en)
WO (1) WO2021221537A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2738885C1 (en) * 2020-04-30 2020-12-18 Андрей Александрович Иващенко Anti-sars-cov-2 viral agent antiprovir
US11648300B1 (en) * 2022-03-31 2023-05-16 Asavi Llc Pharmaceutical combination therapy and prevention with aprotinin + nirmatrelvir of SARS-CoV-2 and/or disease associated with this infection, including COVID-19

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2425691C1 (en) * 2010-07-15 2011-08-10 ВАКЕ спол с.р.о. Aprotinin aerosol for treating viral respiratory infections

Also Published As

Publication number Publication date
WO2021221537A1 (en) 2021-11-04

Similar Documents

Publication Publication Date Title
MX2021013679A (en) Nitrile-containing antiviral compounds.
WO2021207409A3 (en) Small molecule inhibitors of sars-cov-2 viral replication and uses thereof
MX2023000798A (en) Functionalized peptides as antiviral agents.
MX2023005984A (en) Novel spiropyrrolidine derived antiviral agents.
CR20210563A (en) Compounds and methods for the treatment of covid-19
EA202000347A1 (en) ANTI-SARS-CoV-2 VIRAL AGENT ANTIPROVIR
RU2329050C2 (en) Combination of cytochrome-p450-dependent protease inhibitors
EA202190960A1 (en) CONDENSED PYRROLINES THAT ACT AS INHIBITORS OF UBIKVITIN SPECIFIC PROTEASE 30 (USP30)
EA200602130A1 (en) SUBSTITUTED ARYLACYLTIOMETRIC AND RELATED COMPOUNDS; VIRUS REPLICATION INHIBITORS
EA201490163A1 (en) KINURENIN-3-MONOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR USE
EA201490277A1 (en) KINURENIN-3-MONOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF THEIR USE
RU2010138638A (en) NEW APPLICATIONS OF SODIUM 4-PHENYLBUTYRATE (4FB) AND ITS PHARMACEUTICAL ACCEPTABLE SALTS
MX2023005983A (en) Novel spiropyrrolidine derived antiviral agents.
MX2022010748A (en) Methods of treating apol-1 dependent focal segmental glomerulosclerosis.
MX2023006504A (en) Hydroxamate compound, preparation method therefor and application thereof.
DK1656131T3 (en) Use of betaine to treat claudicatio intermittens
EA202000165A1 (en) ANTI-PHK VIRAL, INCLUDING ANTI-SARS-CoV-2 VIRAL PHARMACEUTICAL COMPOSITION AVIFAVIR
EA202000248A1 (en) ANTI-SARS-CoV-2 VIRAL ANTIPROVIR
AR036009A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF VISCERAL PAIN AND GASTROINTESTINAL DISORDERS THAT INCLUDE A BICYCLIC AMINO ACID COMPOUND AND USE OF THIS LAST TO MANUFACTURE SUCH PHARMACEUTICAL COMPOSITION
CL2021003312A1 (en) Composition comprising pridopidine and an analog thereof for the treatment of huntington's disease and its symptoms.
CR20230192A (en) Solid formulation
RU2020124373A (en) PREVENTIVE AND/OR THERAPEUTIC AGENT FOR CATARACT, MEDICAL COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF CATARACT, APPLICATION OF A PPAR ACTIVATOR FOR THE SAME PURPOSE AND EYE DROPS
EA202000300A1 (en) PHARMACEUTICAL KIT FOR COMBINED THERAPY FOR COVID-19 (SARS-CoV-2) AND METHOD FOR ITS USE
MD3996699T2 (en) Combination of ibuprofen and tramadol for relieving pain
UA123399U (en) PHARMACEUTICAL COMPOSITION OF CHOLINE ALPHOSCERATE IN MEDICINAL FOR ORAL USE